References
- Expert Working Group of the European Association for Palliative Care: Morphine in cancer pain: modes of administration. BMJ 1996; 312: 823-6 https://doi.org/10.1136/bmj.312.7034.823
- Sylvester RK, Lindsay SM, Schauer C: The conversion challenge: from intrathecal to oral morphine. Am J Hosp Palliat Care 2004; 21: 143-7 https://doi.org/10.1177/104990910402100214
- Yaksh TL, Rudy TA: Narcotic analgestics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques. Pain 1978; 4: 299-359 https://doi.org/10.1016/0304-3959(77)90145-2
- Lee SJ, Nam SK, Kim JH, Kim HJ, Lee SC, Kim YC: Implantation of an intrathecal drug administration system: a report of two cases. Korean J Pain 2009; 22: 68-73 https://doi.org/10.3344/kjp.2009.22.1.68
- Seo KS, Han KR, Kim SY, Park KE, Kim C: Implantable Intrathecal drug delivery pump in complex regional pain syndrome patient: a case report. Korean J Pain 2009; 22: 74-7 https://doi.org/10.3344/kjp.2009.22.1.74
- Yaksh TL, Rudy TA: Analgesia mediated by a direct spinal action of narcotics. Science 1976; 192: 1357-8 https://doi.org/10.1126/science.1273597
- Wang JK, Nauss LA, Thomas JE: Pain relief by intrathecally applied morphine in man. Anesthesiology 1979; 50: 149-51 https://doi.org/10.1097/00000542-197902000-00013
- Onofrio BM, Yaksh TL, Arnold PG: Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc 1981; 56: 516- 20
- Leavens ME, Hill CS Jr, Cech DA, Weyland JB, Weston JS: Intrathecal and intraventricular morphine for pain in cancer patients: initial study. J Neurosurg 1982; 56: 241-5 https://doi.org/10.3171/jns.1982.56.2.0241
- Rico RC, Hobika GH, Avellanosa AM, Trudnowski RJ, Rempel J, West CR: Use of intrathecal and epidural morphine for pain relief in patients with malignant diseases: a preliminary report. J Med 1982; 13: 223-31
- Auld AW, Maki-Jokela A, Murdoch DM: Intraspinal narcotic analgesia in the treatment of chronic pain. Spine 1985;10: 777-81 https://doi.org/10.1097/00007632-198510000-00014
- Paice JA, Penn RD, Shott S: Intraspinal morphine for chronic pain: a retrospective, multicenter study. J Pain Symptom Manage 1996; 11: 71-80 https://doi.org/10.1016/0885-3924(95)00099-2
- Brazenor GA: Long term intrathecal administration of morphine: a comparison of bolus injection via reservoir with continuous infusion by implanted pump. Neurosurgery 1987; 21: 484-91 https://doi.org/10.1227/00006123-198710000-00008
- Johnston J, Reich S, Bailey A, Sluetz J: Shiley INFUSAID Pump technology. Ann N Y Acad Sci 1988; 531: 57-65 https://doi.org/10.1111/j.1749-6632.1988.tb31812.x
- Belverud S, Mogilner A, Schulder M: Intrathecal pumps. Neurotherapeutics 2008; 5: 114-22 https://doi.org/10.1016/j.nurt.2007.10.070
- Smith HS, Deer TR, Staats PS, Singh V, Sehgal N, Cordner H: Intrathecal drug delivery. Pain Physician 2008; 11(Suppl): 89-104
- Patel VB, Manchikanti L, Singh V, Schultz DM, Hayek SM, Smith HS: Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain. Pain Physician 2009; 12: 345-60
- Anderson VC, Burchiel KJ: A prospective study of longterm intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 1999; 44: 289-300 https://doi.org/10.1097/00006123-199902000-00026
- Angel IF, Gould HJ Jr, Carey ME: Intrathecal morphine pump as a treatment option in chronic pain of nonmalignant origin. Surg Neurol 1998; 49: 92-8 https://doi.org/10.1016/S0090-3019(97)00287-5
- Hassenbusch SJ, Stanton-Hicks M, Covington EC, Walsh JG, Guthrey DS: Long-term intraspinal infusions of opioids in the treatment of neuropathic pain. J Pain Symptom Manage 1995; 10: 527-43 https://doi.org/10.1016/0885-3924(95)00087-F
-
Winkelm
$\ddot{u}$ ller M, Winkelm$\ddot{u}$ ller W: Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996; 85: 458-67 https://doi.org/10.3171/jns.1996.85.3.0458 - Roberts LJ, Finch PM, Goucke CR, Price LM: Outcome of intrathecal opioids in chronic non-cancer pain. Eur J Pain 2001; 5: 353-61 https://doi.org/10.1053/eujp.2001.0255
- Thimineur MA, Kravitz E, Vodapally MS: Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study. Pain 2004; 109: 242-9 https://doi.org/10.1016/j.pain.2004.01.003
- Rauck RL, Cherry D, Boyer MF, Kosek P, Dunn J, Alo K: Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain. J Pain 2003; 4: 441-7 https://doi.org/10.1067/S1526-5900(03)00730-2
- Smith TJ, Coyne PJ, Staats PS, Deer T, Stearns LJ, Rauck RL, et al: An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM). Ann Oncol 2005; 16: 825-33 https://doi.org/10.1093/annonc/mdi156
- Anderson VC, Cooke B, Burchiel KJ: Intrathecal hydromorphone for chronic nonmalignant pain: a retrospective study. Pain Med 2001; 2: 287-97 https://doi.org/10.1046/j.1526-4637.2001.01052.x
- Doggrell SA: Intrathecal ziconotide for refractory pain. Expert Opin Investig Drugs 2004; 13: 875-7 https://doi.org/10.1517/13543784.13.7.875
- Staats PS, Yearwood T, Charapata SG, Presley RW, Wallace MS, Byas-Smith M, et al: Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. JAMA 2004; 291: 63-70 https://doi.org/10.1001/jama.291.1.63
- Van Dongen RT, Crul BJ, van Egmond J: Intrathecal coadministration of bupivacaine diminishes morphine dose progression during long-term intrathecal infusion in cancer patients. Clin J Pain 1999; 15: 166-72 https://doi.org/10.1097/00002508-199909000-00002
- Deer TR, Caraway DL, Kim CK, Dempsey CD, Stewart CD, McNeil KF: Clinical experience with intrathecal bupivacaine in combination with opioid for the treatment of chronic pain related to failed back surgery syndrome and metastatic cancer pain of the spine. Spine J 2002; 2: 274-8 https://doi.org/10.1016/S1529-9430(02)00199-7
- Classen AM, Wimbish GH, Kupiec TC: Stability of admixture containing morphine sulfate, bupivacaine hydrochloride, and clonidine hydrochloride in an implantable infusion system. J Pain Symptom Manage 2004; 28: 603-11 https://doi.org/10.1016/j.jpainsymman.2004.04.011
- Raphael JH, Southall JL, Gnanadurai TV, Treharne GJ, Kitas GD: Long-term experience with implanted intrathecal drug administration systems for failed back syndrome and chronic mechanical low back pain. BMC Musculoskelet Disord 2002; 3: 17 https://doi.org/10.1186/1471-2474-3-17
- Nordberg G, Hedner T, Mellstrand T, Dahlströom B: Pharmacokinetic aspects of intrathecal morphine analgesia. Anesthesiology 1984; 60: 448-54 https://doi.org/10.1097/00000542-198405000-00010
- Moore A, Bullingham R, McQuay H, Allen M, Baldwin D, Cole A: Spinal fluid kinetics of morphine and heroin. Clin Pharmacol Ther 1984; 35: 40-5 https://doi.org/10.1038/clpt.1984.6
- Payne R, Inturrisi CE: CSF distribution of morphine, methadone and sucrose after intrathecal injection. Life Sci 1985; 37: 1137-44 https://doi.org/10.1016/0024-3205(85)90357-1
- Faura CC, Collins SL, Moore RA, McQuay HJ: Systematic review of factors affecting the ratios of morphine and its major metabolites. Pain 1998; 74: 43-53 https://doi.org/10.1016/S0304-3959(97)00142-5
- Pasternak GW, Bodnar RJ, Clark JA, Inturrisi CE: Morphine- 6-glucuronide, a potent mu agonist. Life Sci 1987; 41: 2845-9 https://doi.org/10.1016/0024-3205(87)90431-0
- Hassenbusch SJ, Paice JA, Patt RB, Bedder MD, Bell GK: Clinical realities and economic considerations: economics of intrathecal therapy. J Pain Symptom Manage 1997; 14(3 Suppl): 36-48 https://doi.org/10.1016/S0885-3924(97)00169-3
- Hassenbusch SJ: Cost modeling for alternate routes of administration of opioids for cancer pain. Oncology (Williston Park) 1999; 13(5 Suppl 2): 63-7
- Koulousakis A, Kuchta J, Bayarassou A, Sturm V: Intrathecal opioids for intractable pain syndromes. Acta Neurochir Suppl 2007; 97(Pt 1): 43-8
- Kumar K, Kelly M, Pirlot T: Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy. Surg Neurol 2001; 55: 79-86 https://doi.org/10.1016/S0090-3019(01)00353-6
- Medtronic Inc: Medtronic Synchromed II programmable infusion system clinical reference guide: pain management. 2004
- Krames ES, Olson K: Clinical realities and economic considerations: patient selection in intrathecal therapy. J Pain Symptom Manage 1997; 14(3 Suppl): 3-13 https://doi.org/10.1016/S0885-3924(97)00166-8
- France JC, Jorgenson SS, Lowe TG, Dwyer AP: The use of intrathecal morphine for analgesia after posterolateral lumbar fusion: a prospective, double-blind, randomized study. Spine 1997; 22: 2272-7 https://doi.org/10.1097/00007632-199710010-00015
- Krames ES: Intrathecal infusional therapies for intractable pain: patient management guidelines. J Pain Symptom Manage 1993; 8: 36-46 https://doi.org/10.1016/0885-3924(93)90118-F
- Yaksh TL, Onofrio BM: Retrospective consideration of the doses of morphine given intrathecally by chronic infusion in 163 patients by 19 physicians. Pain 1987; 31: 211-23 https://doi.org/10.1016/0304-3959(87)90037-6
- Ruan X: Drug-related side effects of long-term intrathecal morphine therapy, Pain Physician 2007; 10: 357-66
- Miele VJ, Price KO, Bloomfield S, Hogg J, Bailes JE: A review of intrathecal morphine therapy related granulomas. Eur J Pain 2006; 10: 251-61 https://doi.org/10.1016/j.ejpain.2005.05.002
- Singh PK, Jain R, Mishra S, Kumar S, Bhatnagar S, Deo S: Management of pericatheter cerebrospinal fluid leak after intrathecal implantation of a drug delivery system. Am J Hosp Palliat Care 2008; 25: 237-9 https://doi.org/10.1177/1049909108315520
- Medtronic Inc: Medtronic Synchromed II programmable infusion system clinical reference guide: surgical procedures. 2004
Cited by
- An Improved Method for Intrathecal Catheterization in the Rat vol.26, pp.4, 2010, https://doi.org/10.5625/lar.2010.26.4.393
- Catheter Obstruction of Intrathecal Drug Administration System -A Case Report- vol.25, pp.1, 2012, https://doi.org/10.3344/kjp.2012.25.1.47